Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shen

Showing results (1041-1050 of 1,250) with videos related to

Pageof 125
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109AHong C Shen, Michael J Szymonifka, Divya Kharbanda, et al.
Journal of Medicinal Chemistry|October 5, 2018
Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of ActionXingchun Han, Chengang Zhou, Min Jiang, et al.
Journal of the Royal Society, Interface|March 19, 2020
Decoding collective communications using information theory toolsK R Pilkiewicz, B H Lemasson, M A Rowland, et al.
The British Journal of Dermatology|May 26, 2017
Integrative analyses reveal biological pathways and key genes in psoriasisJ Dou, L Zhang, X Xie, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Mineralocorticoid receptor antagonists: identification of heterocyclic amide replacements in the oxazolidinedione seriesJason M Cox, Hong D Chu, Christine Yang, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2013
Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonistsChristine Yang, Hong C Shen, Zhicai Wu, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitorsHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.
Journal of Medicinal Chemistry|August 16, 2022
Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus InfectionDongdong Chen, Xuefei Tan, Wenming Chen, et al.
Journal of Medicinal Chemistry|March 10, 2023
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV InfectionWeixing Zhang, Lei Guo, Haixia Liu, et al.
ACS Medicinal Chemistry Letters|May 6, 2015
Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonistsChristine Yang, Jaume Balsells, Hong D Chu, et al.
Pageof 125

Showing results (1041-1050 of 1,250) with videos related to

Sort By:
Pageof 125
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109AHong C Shen, Michael J Szymonifka, Divya Kharbanda, et al.
Journal of Medicinal Chemistry|October 5, 2018
Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of ActionXingchun Han, Chengang Zhou, Min Jiang, et al.
Journal of the Royal Society, Interface|March 19, 2020
Decoding collective communications using information theory toolsK R Pilkiewicz, B H Lemasson, M A Rowland, et al.
The British Journal of Dermatology|May 26, 2017
Integrative analyses reveal biological pathways and key genes in psoriasisJ Dou, L Zhang, X Xie, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Mineralocorticoid receptor antagonists: identification of heterocyclic amide replacements in the oxazolidinedione seriesJason M Cox, Hong D Chu, Christine Yang, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2013
Discovery of novel oxazolidinedione derivatives as potent and selective mineralocorticoid receptor antagonistsChristine Yang, Hong C Shen, Zhicai Wu, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitorsHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.
Journal of Medicinal Chemistry|August 16, 2022
Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus InfectionDongdong Chen, Xuefei Tan, Wenming Chen, et al.
Journal of Medicinal Chemistry|March 10, 2023
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV InfectionWeixing Zhang, Lei Guo, Haixia Liu, et al.
ACS Medicinal Chemistry Letters|May 6, 2015
Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonistsChristine Yang, Jaume Balsells, Hong D Chu, et al.
Pageof 125